Zika Virus Vaccines
The live-attenuated vaccine is developed for the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos. The understanding of flavivirus particle structure, the definition of E dimers as the key antigenic target, and a deep understanding of neutralization mechanisms help to develop the vaccine.
Related Conference of Zika Virus Vaccines
October 31-01, 2024
36th International Conference on Vaccines and Immunization
Amsterdam, Netherlands
Zika Virus Vaccines Conference Speakers
Recommended Sessions
- Allergy & Asthma Vaccines
- Antibodies Research
- Chicken Pox Vaccines
- Clinical Immunology & Immunopathology
- Flu Vaccines
- HIV Vaccines
- HPV Vaccines
- Immune System Disorders
- Immunization Challenges
- Immunology
- Infectious and Non-infectious diseases Vaccines
- Onco-Immunology
- Paediatric Vaccines
- Pediatric Immunology
- Plant Vaccines & Veterinary Vaccines
- Recombinant Vaccines
- Stem Cell Immunology
- Therapeutic Cancer Vaccines
- Transplant Immunology
- Travel & Edible Vaccinations
- Vaccine Types
- Vaccine-Induced Immunity
- Vaccines
- Vaccines and Immunology Advancements
- Vaccines Efficacy and Safety
- Zika Virus Vaccines
Related Journals
Are you interested in
- Advances in Vaccine Development - WORLD VACCINES 2025 (France)
- Animal & Plant Derived Vaccines - Vaccine Immunology 2024 (France)
- Animal & Plant Derived Vaccines - Vaccines Summit 2024 (Netherlands)
- Animal Models & Clinical Trials - Vaccine Immunology 2024 (France)
- Animal Models & Clinical Trials - Vaccines Summit 2024 (Netherlands)
- Antibodies: Engineering & Therapeutics - Vaccine Immunology 2024 (France)
- Antibodies: Engineering & Therapeutics - Vaccines Summit 2024 (Netherlands)
- Biomarkers and Immune Monitoring in Vaccines - WORLD VACCINES 2025 (France)
- Cancer BioMarker vaccine - VACCINE CONGRESS 2024 (Spain)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2024 (Spain)
- Cancer, Malaria & TB Vaccines - Vaccine Immunology 2024 (France)
- Cancer, Malaria & TB Vaccines - Vaccines Summit 2024 (Netherlands)
- Cellular Immunology & Latest Innovations - Vaccine Immunology 2024 (France)
- Cellular Immunology & Latest Innovations - Vaccines Summit 2024 (Netherlands)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2024 (Spain)
- Combination & Conjugate Vaccines - Vaccine Immunology 2024 (France)
- Combination & Conjugate Vaccines - Vaccines Summit 2024 (Netherlands)
- Computational Immunology and Vaccine Modeling - WORLD VACCINES 2025 (France)
- COVID19 Vaccines - VACCINE CONGRESS 2024 (Spain)
- Current Research & Future Challenges - Vaccine Immunology 2024 (France)
- Current Research & Future Challenges - Vaccines Summit 2024 (Netherlands)
- DNA & Synthetic Vaccines - Vaccine Immunology 2024 (France)
- DNA & Synthetic Vaccines - Vaccines Summit 2024 (Netherlands)
- DNA Vaccines - Euro Vaccines 2024 (Spain)
- Emerging Infectious Diseases and Global Health - VACCINES WORLD 2024 (Canada)
- Emerging Infectious Diseases and Vaccine Responses - WORLD VACCINES 2025 (France)
- Ethical and Societal Aspects of Vaccination - VACCINES WORLD 2024 (Canada)
- Fish & Poultry Vaccines - Vaccine Immunology 2024 (France)
- Fish & Poultry Vaccines - Vaccines Summit 2024 (Netherlands)
- Geriatric Immunization - Vaccine Immunology 2024 (France)
- Geriatric Immunization - Vaccines Summit 2024 (Netherlands)
- Geriatric Vaccines - VACCINE CONGRESS 2024 (Spain)
- Global Vaccine Access - VACCINE CONGRESS 2024 (Spain)
- Hepatitis Vaccines - Euro Vaccines 2024 (Spain)
- HIV Vaccines - Vaccine Immunology 2024 (France)
- HIV Vaccines - Vaccines Summit 2024 (Netherlands)
- HIV/AIDS Vaccines - Euro Vaccines 2024 (Spain)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2024 (Spain)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2024 (Spain)
- Immunization in Special Populations - VACCINES WORLD 2024 (Canada)
- Immunodiagnostics and Monitoring Immune Responses - VACCINES WORLD 2024 (Canada)
- Immunogenetics and Personalized Vaccinology - VACCINES WORLD 2024 (Canada)
- Immunogenetics and Vaccine Design - WORLD VACCINES 2025 (France)
- Immunological Memory and Vaccine Boosters - WORLD VACCINES 2025 (France)
- Immunology of Vaccines - VACCINE CONGRESS 2024 (Spain)
- Immunology/Animal Models - Euro Vaccines 2024 (Spain)
- Immunopathology and Host-Pathogen Interactions - VACCINES WORLD 2024 (Canada)
- Immunotherapy and Cancer Vaccines - WORLD VACCINES 2025 (France)
- Innate and Adaptive Immune Responses - VACCINES WORLD 2024 (Canada)
- Innovative Immunotherapies - VACCINES WORLD 2024 (Canada)
- Innovative Vaccine Delivery Systems - WORLD VACCINES 2025 (France)
- Mucosal Immunology and Vaccination - WORLD VACCINES 2025 (France)
- Mucosal Vaccines - Euro Vaccines 2024 (Spain)
- Nanotechnology in Vaccine Development - WORLD VACCINES 2025 (France)
- Next Generation Vaccines - VACCINE CONGRESS 2024 (Spain)
- Next-Generation Sequencing in Immunology Research - WORLD VACCINES 2025 (France)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2024 (Spain)
- Novel Vaccine Platforms - VACCINE CONGRESS 2024 (Spain)
- One Health Approach - VACCINE CONGRESS 2024 (Spain)
- Paediatric Vaccination - Vaccine Immunology 2024 (France)
- Paediatric Vaccination - Vaccines Summit 2024 (Netherlands)
- Paediatric Vaccines - VACCINE CONGRESS 2024 (Spain)
- Pediatric Vaccines and Immunization Strategies - WORLD VACCINES 2025 (France)
- Public Health and Vaccination Programs - VACCINES WORLD 2024 (Canada)
- Therapeutic Vaccines for Chronic Diseases - WORLD VACCINES 2025 (France)
- Travel & Edible Vaccines - Vaccine Immunology 2024 (France)
- Travel & Edible Vaccines - Vaccines Summit 2024 (Netherlands)
- Vaccination Strategies for Vector-Borne Diseases - VACCINES WORLD 2024 (Canada)
- Vaccine Adjuvants - VACCINE CONGRESS 2024 (Spain)
- Vaccine Adjuvants - Euro Vaccines 2024 (Spain)
- Vaccine Adjuvants and Immunomodulators - WORLD VACCINES 2025 (France)
- Vaccine Clinical Trials - VACCINE CONGRESS 2024 (Spain)
- Vaccine Delivery Systems - VACCINE CONGRESS 2024 (Spain)
- Vaccine Development and Design - VACCINES WORLD 2024 (Canada)
- Vaccine Development for Emerging Diseases - VACCINE CONGRESS 2024 (Spain)
- Vaccine Development for Zoonotic Diseases - WORLD VACCINES 2025 (France)
- Vaccine Economics and Market Access - VACCINES WORLD 2024 (Canada)
- Vaccine Education and Advocacy - VACCINES WORLD 2024 (Canada)
- Vaccine Equity - VACCINE CONGRESS 2024 (Spain)
- Vaccine Financing - VACCINE CONGRESS 2024 (Spain)
- Vaccine Hesitancy - VACCINE CONGRESS 2024 (Spain)
- Vaccine Hesitancy and Public Health Communication - WORLD VACCINES 2025 (France)
- Vaccine Immunogenicity - VACCINE CONGRESS 2024 (Spain)
- Vaccine Manufacturing - VACCINE CONGRESS 2024 (Spain)
- Vaccine Policy and Regulation - VACCINE CONGRESS 2024 (Spain)
- Vaccine Policy and Regulatory Affairs - WORLD VACCINES 2025 (France)
- Vaccine Production & Development - Vaccine Immunology 2024 (France)
- Vaccine Production & Development - Vaccines Summit 2024 (Netherlands)
- Vaccine Research & Development - Euro Vaccines 2024 (Spain)
- Vaccine Safety - VACCINE CONGRESS 2024 (Spain)
- Vaccine Safety & Efficacy - Vaccines Summit 2024 (Netherlands)
- Vaccine Safety and Adverse Event Monitoring - VACCINES WORLD 2024 (Canada)
- Vaccine Safety and Efficacy - WORLD VACCINES 2025 (France)
- Vaccine Strategies for Autoimmune Diseases - WORLD VACCINES 2025 (France)
- Vaccine Surveillance - VACCINE CONGRESS 2024 (Spain)
- Vaccines - Vaccine Immunology 2024 (France)
- Vaccines - Vaccines Summit 2024 (Netherlands)
- Vaccines & Autism - Vaccine Immunology 2024 (France)
- Vaccines & Autism - Vaccines Summit 2024 (Netherlands)
- Vaccines against Drugs - Vaccines Summit 2024 (Netherlands)
- Vaccines against Drugs - Vaccine Immunology 2024 (France)
- Vaccines against Infectious Diseases - Vaccine Immunology 2024 (France)
- Vaccines Against Infectious Diseases - Vaccines Summit 2024 (Netherlands)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2024 (Spain)
- Vaccines Business Development - Euro Vaccines 2024 (Spain)
- Vaccines Epidemiology - VACCINE CONGRESS 2024 (Spain)
- Vaccines for Immune Mediated Diseases - Vaccine Immunology 2024 (France)
- Vaccines for Immune Mediated Diseases - Vaccines Summit 2024 (Netherlands)
- Vaccines for Neglected Tropical Diseases - WORLD VACCINES 2025 (France)
- Vaccines for Non-Communicable Diseases - VACCINES WORLD 2024 (Canada)
- Vaccines for Older Adults - Euro Vaccines 2024 (Spain)
- Vaccines for Pregnant Women & Neonates - Vaccine Immunology 2024 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines Summit 2024 (Netherlands)
- Vaccines for Respiratory Diseases - Euro Vaccines 2024 (Spain)
- Vaccines for Unconventional Diseases - Vaccine Immunology 2024 (France)
- Vaccines for Unconventional Diseases - Vaccines Summit 2024 (Netherlands)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2024 (Spain)
- Vaccines Immunology - VACCINE CONGRESS 2024 (Spain)
- Vaccines Safety & Efficacy - Euro Vaccines 2024 (Spain)
- Vectors, Adjuvants & Delivery Systems - Vaccine Immunology 2024 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines Summit 2024 (Netherlands)
- Veterinary Vaccines - Vaccines Summit 2024 (Netherlands)
- Veterinary Vaccines - Euro Vaccines 2024 (Spain)